Chionodracine [F1W; H4,15,17K; I9K; S11,21K]

General Information


DRACP ID  DRACP01933

Peptide Name   Chionodracine [F1W; H4,15,17K; I9K; S11,21K]

Sequence  WFGKLYRGKTKVVKKVKGLLKG

Sequence Length  22

UniProt ID  K4Q515 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
SH-SY5Y 0% Killing=64 µM CellTiter-Glo assay Not available 1

Hemolytic Activity  Human erythrocytes: 5% Hemolysis=3µM; 30% Hemolysis=50µM

Normal (non-cancerous) Cytotoxicity  HUVEC: 3.84% Killing=64 µM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01933

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C122H205N33O25

Absent amino acids  ACDEHIMNPQS

Common amino acids  K

Mass  290893

Pl  11.55

Basic residues  8

Acidic residues  0

Hydrophobic residues  8

Net charge  8

Boman Index  -2053

Hydrophobicity  -43.18

Aliphatic Index  92.73

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  6990

Absorbance 280nm  332.86

Polar residues  6

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 30790604

Title  Fish-derived antimicrobial peptides: Activity of a chionodracine mutant against bacterial models and human bacterial pathogens

Doi 10.1016/j.dci.2019.02.012

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPS_12632

DRACP is developed by Dr.Zheng's team.